Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Public attitudes towards genomic risk profiling as a component of routine population screening.

Nicholls SG, Wilson BJ, Craigie SM, Etchegary H, Castle D, Carroll JC, Potter BK, Lemyre L, Little J.

Genome. 2013 Oct;56(10):626-33. doi: 10.1139/gen-2013-0070. Epub 2013 Aug 31.

2.

Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation.

Nicholls SG, Etchegary H, Carroll JC, Castle D, Lemyre L, Potter BK, Craigie S, Wilson BJ; CIHR Emerging Team in Genomics and Screening.

BMC Med Genomics. 2016 May 23;9(1):25. doi: 10.1186/s12920-016-0186-5.

3.

Playing a part in research? University students' attitudes to direct-to-consumer genomics.

Vayena E, Ineichen C, Stoupka E, Hafen E.

Public Health Genomics. 2014;17(3):158-68. doi: 10.1159/000360257. Epub 2014 Apr 25.

4.
5.

Pediatricians' attitudes toward expanding newborn screening.

Acharya K, Ackerman PD, Ross LF.

Pediatrics. 2005 Oct;116(4):e476-84.

PMID:
16199673
6.

Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes.

Kerruish NJ.

J Med Ethics. 2011 Jun;37(6):348-53. doi: 10.1136/jme.2010.039206. Epub 2011 Jan 25.

PMID:
21266388
7.

Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study.

Smit AK, Keogh LA, Newson AJ, Hersch J, Butow P, Cust AE.

Public Health Genomics. 2015;18(5):309-17. doi: 10.1159/000439246. Epub 2015 Sep 22.

PMID:
26390062
8.

Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.

Hiraki S, Ormond KE, Kim K, Ross LF.

Am J Med Genet A. 2006 Nov 1;140(21):2312-9.

PMID:
17036312
9.

How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study.

Ostergren JE, Gornick MC, Carere DA, Kalia SS, Uhlmann WR, Ruffin MT, Mountain JL, Green RC, Roberts JS; PGen Study Group.

Public Health Genomics. 2015;18(4):216-24. doi: 10.1159/000431250. Epub 2015 Jun 16.

10.

Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing.

Joseph G, Chen F, Harris-Wai J, Puck JM, Young C, Koenig BA.

Pediatrics. 2016 Jan;137 Suppl 1:S36-46. doi: 10.1542/peds.2015-3731H.

11.

The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer.

Hawken SJ, Greenwood CM, Hudson TJ, Kustra R, McLaughlin J, Yang Q, Zanke BW, Little J.

Hum Genet. 2010 Jul;128(1):89-101. doi: 10.1007/s00439-010-0828-1. Epub 2010 May 1.

12.

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.

Carere DA, VanderWeele T, Moreno TA, Mountain JL, Roberts JS, Kraft P, Green RC; PGen Study Group.

BMC Med Genomics. 2015 Oct 15;8:63. doi: 10.1186/s12920-015-0140-y.

13.

Interest in genetic testing among first-degree relatives of colorectal cancer patients.

Kinney AY, Choi YA, DeVellis B, Kobetz E, Millikan RC, Sandler RS.

Am J Prev Med. 2000 Apr;18(3):249-52.

PMID:
10722992
14.

Maternal attitudes to newborn screening for fragile X syndrome.

Christie L, Wotton T, Bennetts B, Wiley V, Wilcken B, Rogers C, Boyle J, Turner C, Hansen J, Hunter M, Goel H, Field M.

Am J Med Genet A. 2013 Feb;161A(2):301-11. doi: 10.1002/ajmg.a.35752. Epub 2013 Jan 9.

PMID:
23303663
15.

Gain versus loss-framed messaging and colorectal cancer screening among African Americans: A preliminary examination of perceived racism and culturally targeted dual messaging.

Lucas T, Hayman LW Jr, Blessman JE, Asabigi K, Novak JM.

Br J Health Psychol. 2016 May;21(2):249-67. doi: 10.1111/bjhp.12160. Epub 2015 Sep 1.

PMID:
26333060
16.

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.

Gray SW, Hicks-Courant K, Lathan CS, Garraway L, Park ER, Weeks JC.

J Oncol Pract. 2012 Nov;8(6):329-35, 2 p following 335. doi: 10.1200/JOP.2012.000626. Epub 2012 Aug 7.

17.

Postgenomic medicine. Presymptomatic testing for prediction and prevention.

McCabe LL, McCabe ER.

Clin Perinatol. 2001 Jun;28(2):425-34.

PMID:
11499063
18.

Perspectives on colorectal cancer screening: a focus group study.

Goel V, Gray R, Chart P, Fitch M, Saibil F, Zdanowicz Y.

Health Expect. 2004 Mar;7(1):51-60.

19.

Patient and provider barriers to colorectal cancer screening in the primary care safety-net.

O'Malley AS, Beaton E, Yabroff KR, Abramson R, Mandelblatt J.

Prev Med. 2004 Jul;39(1):56-63.

PMID:
15207986
20.

Broadening the examination of sociocultural constructs relevant to African-American colorectal cancer screening.

Thompson VL, Harris J, Clark EM, Purnell J, Deshpande AD.

Psychol Health Med. 2015;20(1):47-58. doi: 10.1080/13548506.2014.894639. Epub 2014 Mar 14.

Supplemental Content

Support Center